QTX3046 in Patients With KRAS G12D Mutations

Clinical trial NCT06428500 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06428500
Sponsor: Quanta Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-05-30
Primary completion: 2027-07-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.